These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3218011)

  • 1. [Total necrosis of the urinary system as a result of drug therapy].
    Al'berton VM; Tukmanbetov DG
    Urol Nefrol (Mosk); 1988; (3):65-6. PubMed ID: 3218011
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacologic properties and indications of modern vasodilator agents. 2: Indications and side effects of vasodilator agents].
    Langnickel R; Bluth R
    Z Arztl Fortbild (Jena); 1985; 79(20):867-73. PubMed ID: 3936287
    [No Abstract]   [Full Text] [Related]  

  • 3. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical trial with Lidoflazine (R-7.904) in coronary insufficiency].
    Maciel LR; do Amarilho IP; Lion MF
    Rev Paul Med; 1970 Sep; 76(7):89-92. PubMed ID: 5511909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Organic nitrates. I. Mechanism of action and new therapeutic approaches in myocardial ischemia].
    Schrör K
    Internist (Berl); 1995 Apr; 36(4):392-7. PubMed ID: 7775091
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA
    Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cavinton in the therapy of cerebrovascular disorders].
    Kalvach P; Bauer J; Ságová V
    Cesk Neurol Neurochir; 1982 Nov; 45(6):380-5. PubMed ID: 7151202
    [No Abstract]   [Full Text] [Related]  

  • 8. [Differentiated therapy of patients with chronic coronary insufficiency].
    Miasnikov LA; Metelitsa VI
    Ter Arkh; 1969 Apr; 41(4):74-82. PubMed ID: 4191108
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of nifedipine and a minoxidil-like arterial vasodilator on myocardial ischemia under dynamic electrocardiographic monitoring].
    Strozzi C; Cocco G; Tasini MT; Padula A; Rizzo A; Alfiero R; Urso L; Montanari L; Portaluppi F
    Clin Ter; 1986 Jul; 118(1):9-12. PubMed ID: 3742977
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arrhythmias with syncope, coronarodilators and antiarrhythmics].
    Fouchard J; Badoual P; Soulié J; Normand JP; Colcher E; Villemin I
    Coeur Med Interne; 1972; 11(1):111-21. PubMed ID: 5014839
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy of drug therapy of patients with coronary arteriosclerosis].
    Ignat'ev MV
    Sov Med; 1969 Dec; 32(12):126-7. PubMed ID: 5376010
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of acute and chronic coronary insufficiency with carbochromen].
    Popov VG; Beljakova TI; Sophijeva IJ
    Arzneimittelforschung; 1970 Mar; 20():467-8. PubMed ID: 5468733
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cutaneous pigmentation during treatments with amiodarone chlorhydrate].
    Labouche F; Massé R; Jan A; Grullier A; Herry B; Bailleux A
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(1):27-30. PubMed ID: 4254762
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the clinical use of a new drug in the therapy of coronary insufficiency].
    Bracchetti D; Spada E
    G Clin Med; 1966 Dec; 47(12):1261-82. PubMed ID: 4173047
    [No Abstract]   [Full Text] [Related]  

  • 16. [The role of adrenergic stimulation in myocardial ischemia and its correction with beta-blocking agents].
    Invernizzi G; Lussana S
    Minerva Cardioangiol; 1967 Jul; 15(7):475-80. PubMed ID: 5615131
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Clinical evaluation of perhexiline maleate in the treatment of chronic cardiac arrhythmias of patients with coronary heart disease.
    Sukerman M
    Postgrad Med J; 1973 Apr; 49():Suppl 3:46-52. PubMed ID: 4587032
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic cerebral vascular insufficiency and mental deterioration].
    del Ser T; Bartolomé MP; Bermejo Pareja F
    Med Clin (Barc); 1987 Nov; 89(17):748-52. PubMed ID: 3320606
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with N,N'-dimethyl-N,N'-bis-(3-(3',4',5'-trimethoxybenzoyloxy)-propyl)-ethylenediamine dihydrochloride (hexobendine)].
    Zimmermann W
    Arzneimittelforschung; 1968 Aug; 18(8):1112-4. PubMed ID: 5756048
    [No Abstract]   [Full Text] [Related]  

  • 20. [We need molsidomine for complete prevention of ischemia. Interview with Prof. Rudolph on the therapy of coronary heart disease].
    Rudolph W
    Fortschr Med; 1986 Apr; 104(13):52. PubMed ID: 3754533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.